With Abbott Laboratories set to release its earnings next week, ABT stock presents an intriguing contrarian trade following a weak spell.

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank ...

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and ...